Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › 18F-tagged inhibitors of prostate specific membrane antigen (PSMA) and their use as imaging agents for prostate cancer

18F-tagged inhibitors of prostate specific membrane antigen (PSMA) and their use as imaging agents for prostate cancer

US Patent 12054458 · Granted Aug 6, 2024

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Double-labeled probe for molecular imaging and use thereof2024
Double-labeled probe for molecular imaging and use thereof2024
Double-labeled probe for molecular imaging and use thereof2024
Double-labeled probe for molecular imaging and use thereof2024
Double-labeled probe for molecular imaging and use thereof2024
Bispecific anti-CCL2 antibodies2024
Use of labeled inhibitors of prostate specific membrane antigen (PSMA), as agent2024
Use of labeled inhibitors of prostate specific membrane antigen (PSMA), as agent2024
Use of labeled inhibitors of prostate specific membrane antigen (PSMA), as agent2024
Use of labeled inhibitors of prostate specific membrane antigen (PSMA), as agent2024
Labeled inhibitors of prostate specific membrane antigen (PSMA) as agents for th2024
Labeled inhibitors of prostate specific membrane antigen (PSMA) as agents for th2024